After finding success investing in surgery centers, dermatological practices and other front-line healthcare providers, private equity is now pushing beyond medicine’s frontlines and into clinical research. Chicago-based BPOC in April launched platform company Atlas Clinical Research to capitalize on a critical research backbone of the pharmaceutical industry. It’s been busy dealmaking since.
To read the entire story, you must be logged in.
Please log in now or register with us.
